By Matthew Perlman ( November 28, 2018, 7:32 PM EST) -- Mylan Pharmaceuticals urged a New Jersey federal judge on Tuesday to allow it to add three consumer witnesses in its case accusing Celgene Corp. of stifling generic competition for the brand-name cancer drugs Thalomid and Revlimid, saying they can testify about the scheme's impact on drug prices....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.